Application of AS101 for the Treatment of Thrombocytopenia in Solid Tumor Patients

PHASE2TerminatedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 31, 2009

Primary Completion Date

August 31, 2010

Study Completion Date

August 31, 2010

Conditions

Chemotherapy Induced Thrombocytopenia

Interventions

DRUG

AS101

intravenous infusions of 3mg/m2 AS101 twice a week in addition to the standard chemotherapy regimen during the following 4 chemotherapy courses.

Trial Locations (1)

Meir Medical Center, Kfar Saba